AJANTA PHARMA Fact Sheet, AJANTA PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Fact Sheet    (AJPH)


FREE Replay: See How Richa Picks Potentially Crorepati-Making Stocks...


Here is the latest financial fact sheet of AJANTA PHARMA. For more details, see the AJANTA PHARMA quarterly results and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

AJANTA PHARMA Price History

Price Rs 1,721.0
Mkt Cap Rs m 147,002
Vol '000 1.0
P/E X 20.6
P/CF X 19.1
EPS (TTM) Rs 83.4
1 Day % 1.2
No. of shares m 85.42
1 Week % 0.9
1 Month % -1.0
1 Year % -12.0
52 week H/L Rs 2,420.0/1,593.3
As on May 26, 2022 10:20:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AJANTA PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
AJANTA PHARMA EQUITY SHARE DATA
High Rs2,1501,8181,4221,5441,883 
Low Rs1,3511,1068988401,258 
Sales per share (Unadj.) Rs223.3241.0235.6296.6334.0 
Earnings per share (Unadj.) Rs57.653.244.453.675.6 
Diluted earnings per shareRs59.354.945.354.876.6 
Cash flow per share (Unadj.) Rs64.560.052.664.689.0 
Dividends per share (Unadj.) Rs13.0009.0013.009.50 
Adj. dividends per shareRs13.390.009.1913.289.62 
Avg Dividend yield %0.700.81.10.6 
Book value per share (Unadj.) Rs177.9231.8257.2297.8346.1 
Adj. book value per shareRs183.3238.8262.7304.2350.6 
Shares outstanding (eoy) m88.0188.0187.2587.2586.53 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x7.86.14.94.04.7 
Avg P/E ratio x30.427.526.122.220.8 
P/CF ratio (eoy) x27.124.422.018.517.7 
Price / Book Value ratio x9.86.34.54.04.5 
Dividend payout %22.6020.324.312.6 
Avg Mkt Cap Rs m154,031128,677101,190103,993135,898 
No. of employees `000NANANANANA 
Total wages/salary Rs m2,9543,7654,3074,8565,483 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
AJANTA PHARMA INCOME DATA
Net Sales Rs m19,64921,20720,55425,87928,897 
Other income Rs m239242211922260 
Total revenues Rs m19,88721,44820,76526,80129,157 
Gross profit Rs m6,8696,5845,6646,7949,986 
Depreciation Rs m6125967219571,161 
Interest Rs m1441211983 
Profit before tax Rs m6,4826,2265,1436,6409,002 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,4131,5391,2731,9632,463 
Profit after tax Rs m5,0684,6863,8704,6776,539 
Gross profit margin %35.031.027.626.334.6 
Effective tax rate %21.824.724.829.627.4 
Net profit margin %25.822.118.818.122.6 
AJANTA PHARMA BALANCE SHEET DATA
Current assets Rs m8,50612,23613,00517,81122,178 
Current liabilities Rs m2,4673,4614,9847,4558,388 
Net working cap to sales %30.741.439.040.047.7 
Current ratio x3.43.52.62.42.6 
Inventory Days Days4247433653 
Debtors Days Days688119 
Net fixed assets Rs m9,72712,02416,05317,90918,912 
Share capital Rs m177177175175174 
"Free" reserves Rs m15,48420,22122,26625,80929,777 
Net worth Rs m15,66020,39722,44125,98429,951 
Long term debt Rs m10107716 
Total assets Rs m18,23324,26029,05835,72041,090 
Interest coverage x477.61,519.4444.356.7109.8 
Debt to equity ratio x00000 
Sales to assets ratio x1.10.90.70.70.7 
Return on assets %27.919.313.413.416.1 
Return on equity %32.423.017.218.021.8 
Return on capital %41.430.523.026.030.3 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m11,47711,66710,68214,42118,097 
Fx outflow Rs m2,2061,6162,1021,6422,315 
Net fx Rs m9,27110,0528,58012,77815,782 
AJANTA PHARMA CASH FLOW
From Operations Rs m 6,093 2,811 3,745 4,568 5,763 
From Investments Rs m -3,831 -2,561 -2,228 -2,244 -2,824 
From Financial Activity Rs m -2,018 -2 -1,475 -1,286 -3,183 
Net Cashflow Rs m 244 248 43 1,037 -244 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 70.5%
Institution 21.4%
Non-Institution 8.1%
Total 100.0%
Free Float 29.5%
Pledged promoter holdings 16.6%
Shareholding as on Mar 2022
 

Company Information

Regd Off Ajanta House, Charkop , Kandivali (W), Mumbai - 400067
E-mail info@ajantapharma.com Web www.ajantapharma.com
Tel 91-22-66061000 Fax +91-22-66061200/300
Sector PHARMACEUTICALS Group Vimal Agrawal
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
Auditor Kapoor & Parekh Assoc.
CHM: Mannalal B Agrawal COMP SEC: Gaurang Shah YEAR OF INC: 1979 BSE CODE: 532331 FV (Rs): 2 DIV YIELD (%): 0.6

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

Sensex Trades Marginally Higher; Power & FMCG Stocks Under Pressure(10:30 am)

Asian share markets are higher today following gains on Wall Street as investors looked at the optimistic side of Federal Reserve minutes that reiterated plans to raise interest rates.

Views on news

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA - INDOCO REMEDIES COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS